ESC 2024 Insights


 

ESC 2024 Insights: Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation: Results of the Phase 3 RESTORE-1 Trial

135 views
September 23, 2024
Comments 0
Login to view comments. Click here to Login